reports
- Jonathan Moreland
- Jonathan Moreland
Relay Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Co...
Relay Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference CAMBRIDGE, Mass., Jan. 07, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, today announced that Sanjiv Patel, M.D., President and Chief Executive Officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025 at 7:30 a.m. PT. The presentation will be webcast live and may be accessed through Relay Therapeutics’ website under...
- Jonathan Moreland
MHI PIONEER MUNICIPAL HIGH INCOME TRUST
ETON ETON PHARMACEUTICALS
RLAY RELAY THERAPEUTICS
BIGZ BLACKROCK INNOVATION AND GROWTH TST
BUKS BUTLER NATIONAL CORP
GLSI GREENWICH LIFESCIENCES INC
MEGI MAINSTAY CBRE GBL INFRASTRUCTURE MEGATRENDS FD
MIO PIONEER MUN HIGH INCOME OPPORTUNITIES FD INC
EVM EATON VANCE INSD CALIF MUN BD FD
Relay Therapeutics Announces Updated Interim Data for RLY-2608 + Fulve...
Relay Therapeutics Announces Updated Interim Data for RLY-2608 + Fulvestrant Demonstrating Continued Maturation of Clinically Meaningful Progression Free Survival New interim data show 11.4-month median PFS in 2L patients with PI3Kα-mutated, HR+/HER2- metastatic breast cancer at RP2D 39% confirmed ORR across all patients & 67% in patients with kinase mutations at RP2D Data support planned initiation of 2L pivotal study in 2025 Next-generation triplet combination with atirmociclib (CDK4-selective) initiated & ribociclib triplet combination ongoing Relay Therapeutics to host a conference ...
Relay Therapeutics to Present Updated Clinical Data on RLY-2608 in HR+...
Relay Therapeutics to Present Updated Clinical Data on RLY-2608 in HR+/HER2- Breast Cancer at 2024 San Antonio Breast Cancer Symposium Company to host conference call on Wednesday, December 11, 2024 at 7am ET CAMBRIDGE, Mass., Dec. 09, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, today announced that updated clinical data for RLY-2608 600mg BID + fulvestrant in patients with PI3Kα-mutated, HR+, HER2- locally advanced or metastatic breast...
Relay Therapeutics and Elevar Therapeutics Announce Exclusive Global L...
Relay Therapeutics and Elevar Therapeutics Announce Exclusive Global Licensing Agreement for Lirafugratinib in FGFR2-Driven Cholangiocarcinoma and Other Solid Tumors Global licensing agreement grants Elevar Therapeutics worldwide rights to develop and commercialize lirafugratinib (RLY-4008) Lirafugratinib is a potential best-in-class FGFR2 inhibitor that has shown differentiated efficacy in FGFR2-driven cholangiocarcinoma and demonstrated durable responses across multiple other types of FGFR2-altered solid tumors Relay Therapeutics has potential to receive up to $500 million in upfront, r...
Relay Therapeutics to Participate in Upcoming Investor Conferences
Relay Therapeutics to Participate in Upcoming Investor Conferences CAMBRIDGE, Mass., Nov. 07, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, today announced that management will participate in the following upcoming fireside chats: Guggenheim Healthcare Innovation Conference on Wednesday, November 13, 2024 at 10:00 a.m. ETStifel 2024 Healthcare Conference on Monday, November 18, 2024 at 10:55 a.m. ETJefferies London Healthcare Conference on...
Relay Therapeutics Reports Third Quarter 2024 Financial Results and Co...
Relay Therapeutics Reports Third Quarter 2024 Financial Results and Corporate Highlights Reported interim RLY-2608 data demonstrating 9.2-month median PFS in heavily pre-treated patients with PI3Kα-mutated, HR+/HER2- metastatic breast cancer at RP2D Plan to initiate 2L pivotal trial of RLY-2608 + fulvestrant in 2025 Approximately $840 million in cash, cash equivalents and investments at end of Q3 2024, expected to fund operations into second half of 2027 CAMBRIDGE, Mass., Nov. 06, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the dru...
Relay Therapeutics to Announce Third Quarter 2024 Financial Results an...
Relay Therapeutics to Announce Third Quarter 2024 Financial Results and Corporate Highlights on November 6, 2024 CAMBRIDGE, Mass., Oct. 30, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, will report third quarter 2024 financial results and corporate highlights after the U.S. financial markets close on Wednesday, November 6, 2024. About Relay Therapeutics Relay Therapeutics (Nasdaq: RLAY) is a clinical-stage precision medicine company t...
- Jonathan Moreland
- Jonathan Moreland
TTSH TILE SHOP HOLDINGS INC.
MOFG MIDWESTONE FINANCIAL GROUP
MEI METHODE ELECTRONICS INC.
KVHI KVH INDUSTRIES INC.
GDOT GREEN DOT CORPORATION CLASS A
CTRN CITI TRENDS INC.
CRMT AMERICA'S CAR-MART INC.
CODI COMPASS DIVERSIFIED HOLDINGS
CDXS CODEXIS
AHH ARMADA HOFFLER PROPERTIES INC.
NEWT NEWTEK BUSINESS SERVICES INC.
A0JMXQ INDIA CAPITAL GROWTH FUND LTD.
RLMD RELMADA THERAPEUTICS
CULP CULP INC.
EBF ENNIS
APTV APTIV PLC
NANX NANOPHASE TECHNOLOGIES CORP.
AXR AMREP
ETON ETON PHARMACEUTICALS
STIM STIMSONITE CORP
INMB INMUNE BIO
NFE INC.
CAPR NEW FORTRESS ENERGY
EPSN CAPRICOR THERAPEUTICS
FBIO EPSILON ENERGY LIMITED
WSC FABIEN CORP
VRDN WILLSCOT MOBILE MINI HOLDINGS CORP
CTLP VIRIDIAN THERAPEUTICS INC
SMMT CANTALOUPE
PFBX INC.
BMEA SUMMIT THERAPEUTICS INC
FTHY PEOPLES FINANCIAL CORP. (MISSISSIPPI)
ASLE BIOMEA FUSION
BHVN INC.
BIGZ FIRST TRUST HIGH YIELD OPPORTUNITIES 2027 TERM FUND
BUKS AERSALE CORP
ECBK BIOHAVEN LTD
CDIO BLACKROCK INNOVATION AND GROWTH TST
GRNT BUTLER NATIONAL CORP
GTE ECB BANCORP INC.
CRBP CARDIO DIAGNOSTICS HLDGS INC
BMEZ GRANITE RIDGE RESOURCES INC
ASGI GRAN TIERRA ENERGY INC.
SYRS CORBUS PHARMACEUTICALS HOLDINGS INC.
PEO BLACKROCK HEALTH SCIENCES TERM TRUST
XPER ABERDEEN STANDARD GLOBAL INFRASTRUCTURE INCOME FUND
OMIC SYROS PHARMACEUTICALS INC.
PMN PETROLEUM & RESOURCES CORPORATION
BNTC XPERI INC
CLNN SINGULAR GENOMICS SYSTEMS INC
BNZI PROMIS NEUROSCIENCES INC.
SIRI BENITEC BIOPHARMA INC
CLENE INC
BANZAI INTERNATIONAL INC
SIRIUS XM HLDGS INC NEW
- Jonathan Moreland
SAIC SCIENCE APPLICATIONS INTERNATIONAL CORP.
PAYC PAYCOM SOFTWARE INC.
MOFG MIDWESTONE FINANCIAL GROUP
AHH ARMADA HOFFLER PROPERTIES INC.
INMB INMUNE BIO
GRX INC.
VRDN THE GABELLI HEALTHCARE & WELLNESSRX TRUST
CTLP VIRIDIAN THERAPEUTICS INC
BIGZ CANTALOUPE
BUKS INC.
GLSI BLACKROCK INNOVATION AND GROWTH TST
BMEZ BUTLER NATIONAL CORP
PEO GREENWICH LIFESCIENCES INC
DV BLACKROCK HEALTH SCIENCES TERM TRUST
BNTC PETROLEUM & RESOURCES CORPORATION
DEVRY INC.
BENITEC BIOPHARMA INC
- Jonathan Moreland
KVHI KVH INDUSTRIES INC.
HNRG HALLADOR ENERGY CO.
I3N CHART INDUSTRIES INC.
CTRN CITI TRENDS INC.
CRMT AMERICA'S CAR-MART INC.
CODI COMPASS DIVERSIFIED HOLDINGS
CDXS CODEXIS
NEWT NEWTEK BUSINESS SERVICES INC.
A0JMXQ INDIA CAPITAL GROWTH FUND LTD.
RLMD RELMADA THERAPEUTICS
CULP CULP INC.
HTLD HEARTLAND EXPRESS INC.
ORN ORION GROUP HOLDINGS
AEHR AEHR TEST SYSTEMS
APTV APTIV PLC
CLAR CLARUS CORPORATION
JEF JEFFERIES FINANCIAL GROUP INC.
NANX NANOPHASE TECHNOLOGIES CORP.
AXR AMREP
ETON ETON PHARMACEUTICALS
STIM STIMSONITE CORP
GCI GANNETT CO. INC.
CAPR CAPRICOR THERAPEUTICS
EPSN EPSILON ENERGY LIMITED
FBIO FABIEN CORP
WSC WILLSCOT MOBILE MINI HOLDINGS CORP
VRDN VIRIDIAN THERAPEUTICS INC
PFBX PEOPLES FINANCIAL CORP. (MISSISSIPPI)
BASE COUCHBASE
FTHY INC.
PCT FIRST TRUST HIGH YIELD OPPORTUNITIES 2027 TERM FUND
AMLX PURECYCLE TECHNOLOGIES INC
ASLE AMYLYX PHARMACEUTICALS INC
BHVN AERSALE CORP
BUKS BIOHAVEN LTD
ECBK BUTLER NATIONAL CORP
VEEE ECB BANCORP INC.
CDIO TWIN VEE POWERCATS CO
GTE CARDIO DIAGNOSTICS HLDGS INC
CRBP GRAN TIERRA ENERGY INC.
BMEZ CORBUS PHARMACEUTICALS HOLDINGS INC.
BNZI BLACKROCK HEALTH SCIENCES TERM TRUST
BTSG BANZAI INTERNATIONAL INC
ASGI BRIGHTSPRING HEALTH SERVICES INC.
SYRS ABERDEEN STANDARD GLOBAL INFRASTRUCTURE INCOME FUND
PEO SYROS PHARMACEUTICALS INC.
XPER PETROLEUM & RESOURCES CORPORATION
OMIC XPERI INC
PMN SINGULAR GENOMICS SYSTEMS INC
PROMIS NEUROSCIENCES INC.
- Jonathan Moreland
UEC URANIUM ENERGY CORP
SPWH SPORTMANS WAREHOUSE HOLDINGS
PSEC PROSPECT CAPITAL CORPORATION
PENN PENN NATIONAL GAMING INC.
PBF PBF ENERGY INC. CLASS A
MTDR MATADOR RESOURCES COMPANY
HNRG HALLADOR ENERGY CO.
I3N CHART INDUSTRIES INC.
CTRN CITI TRENDS INC.
CRMT AMERICA'S CAR-MART INC.
CODI COMPASS DIVERSIFIED HOLDINGS
CGNX COGNEX CORPORATION
RLMD RELMADA THERAPEUTICS
CULP CULP INC.
HTLD HEARTLAND EXPRESS INC.
ORN ORION GROUP HOLDINGS
CIA CITIZENS INC. CL A
AEHR AEHR TEST SYSTEMS
SMRT SMARTSPACE SOFTWARE
APTV APTIV PLC
CLAR CLARUS CORPORATION
TALO TALOS ENERGY INC.
JEF JEFFERIES FINANCIAL GROUP INC.
TCPC BLACKROCK TCP CAPITAL CORP.
ETON ETON PHARMACEUTICALS
STIM STIMSONITE CORP
GCI GANNETT CO. INC.
EPSN EPSILON ENERGY LIMITED
WSC WILLSCOT MOBILE MINI HOLDINGS CORP
VRDN VIRIDIAN THERAPEUTICS INC
GRNT GRANIT SKOPKE
TDUP THREDUP INC.
ZVIA ZEVIA PBC
FTHY FIRST TRUST HIGH YIELD OPPORTUNITIES 2027 TERM FUND
PCT PURECYCLE TECHNOLOGIES INC
AMLX AMYLYX PHARMACEUTICALS INC
HR HEALTHCARE TRUST OF AMERICA INC.
ASLE AERSALE CORP
ECBK ECB BANCORP INC.
CRGY CRESCENT ENERGY CO
VEEE TWIN VEE POWERCATS CO
GTE GRAN TIERRA ENERGY INC.
BMEZ BLACKROCK HEALTH SCIENCES TERM TRUST
BTSG BRIGHTSPRING HEALTH SERVICES INC.
SYRS SYROS PHARMACEUTICALS INC.
PEO PETROLEUM & RESOURCES CORPORATION
XPER XPERI INC
ISPO INSPIRATO INCORPORATED
OMIC SINGULAR GENOMICS SYSTEMS INC
- Jonathan Moreland
TTSH TILE SHOP HOLDINGS INC.
SPWH SPORTMANS WAREHOUSE HOLDINGS
PSEC PROSPECT CAPITAL CORPORATION
PENN PENN NATIONAL GAMING INC.
PBF PBF ENERGY INC. CLASS A
MTDR MATADOR RESOURCES COMPANY
I3N CHART INDUSTRIES INC.
GLP GLOBAL PARTNERS LP
CRWS CROWN CRAFTS INC.
CODI COMPASS DIVERSIFIED HOLDINGS
CHCT COMMUNITY HEALTHCARE TRUST INCORPORATED
BEN FRANKLIN RESOURCES INC.
RLMD RELMADA THERAPEUTICS
CULP CULP INC.
HTLD HEARTLAND EXPRESS INC.
MYRG MYR GROUP INC.
RIGN TRANSOCEAN LTD.
GBDC GOLUB CAPITAL BDC INC.
HLT HILTON WORLDWIDE HOLDINGS INC
APTV APTIV PLC
CLAR CLARUS CORPORATION
APPN APPIAN
CNX CONSOL ENERGY INC.
TALO TALOS ENERGY INC.
TCPC BLACKROCK TCP CAPITAL CORP.
ETON ETON PHARMACEUTICALS
STIM STIMSONITE CORP
ONEW ONEWATER MARINE
ADV ADVANTAGE SOLUTIONS INC (A)
GRNT GRANIT SKOPKE
FTCI FTC SOLAR
INBX INC.
TDUP INHIBRX
FTHY INC.
AMLX THREDUP INC.
CRGY FIRST TRUST HIGH YIELD OPPORTUNITIES 2027 TERM FUND
PFHC AMYLYX PHARMACEUTICALS INC
BTSG CRESCENT ENERGY CO
SYRS PROFRAC HLDG CORP
PEO BRIGHTSPRING HEALTH SERVICES INC.
XPER SYROS PHARMACEUTICALS INC.
PETROLEUM & RESOURCES CORPORATION
XPERI INC
- Jonathan Moreland
PENN PENN NATIONAL GAMING INC.
PAYC PAYCOM SOFTWARE INC.
MTDR MATADOR RESOURCES COMPANY
GLP GLOBAL PARTNERS LP
CODI COMPASS DIVERSIFIED HOLDINGS
FIVN FIVE9 INC.
FRD FRIEDMAN INDUSTRIES INC.
APTV APTIV PLC
APPN APPIAN
ZM ZOOM VIDEO COMMUNICATIONS
ETON INC.
INBX ETON PHARMACEUTICALS
PET INHIBRX
LUNR INC.
SYRS WAG GROUP CO
PEO INTUITIVE MACHINES INC
XPER SYROS PHARMACEUTICALS INC.
PETROLEUM & RESOURCES CORPORATION
XPERI INC
- Jonathan Moreland
PSEC PROSPECT CAPITAL CORPORATION
PBF PBF ENERGY INC. CLASS A
PAYC PAYCOM SOFTWARE INC.
MTDR MATADOR RESOURCES COMPANY
CTRN CITI TRENDS INC.
RLMD RELMADA THERAPEUTICS
CULP CULP INC.
MYRG MYR GROUP INC.
HLT HILTON WORLDWIDE HOLDINGS INC
CNX CONSOL ENERGY INC.
ZM ZOOM VIDEO COMMUNICATIONS
GRNT INC.
FTHY GRANIT SKOPKE
PFHC FIRST TRUST HIGH YIELD OPPORTUNITIES 2027 TERM FUND
GNLX PROFRAC HLDG CORP
NPWR GENELUX CORP
PEO NET POWER INC
PETROLEUM & RESOURCES CORPORATION
Relay Therapeutics Announces Pricing of Public Offering of Common Stoc...
Relay Therapeutics Announces Pricing of Public Offering of Common Stock CAMBRIDGE, Mass., Sept. 10, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, announced today the pricing of an underwritten public offering of 28,571,429 shares of its common stock at a public offering price of $7.00 per share. Relay Therapeutics also granted the underwriters a 30-day option to purchase up to an additional 4,285,714 shares of its common stock. The gross pr...
Relay Therapeutics Announces Proposed Public Offering of Common Stock
Relay Therapeutics Announces Proposed Public Offering of Common Stock CAMBRIDGE, Mass., Sept. 09, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, announced today that it has commenced an underwritten public offering of $200 million of shares of its common stock. Relay Therapeutics also intends to grant the underwriters a 30-day option to purchase up to an additional fifteen percent (15%) of the shares of common stock offered in the public off...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.